Formosa Laboratories Inc
TWSE:4746
Formosa Laboratories Inc
TWSE:4746
Price:
73.6
TWD
0.96%
Market Closed
Market Cap:
8.9B
TWD
Balance Sheet
Balance Sheet Decomposition
Formosa Laboratories Inc
Formosa Laboratories Inc
| Current Assets | 5.6B |
| Cash & Short-Term Investments | 2.6B |
| Receivables | 997m |
| Other Current Assets | 2B |
| Non-Current Assets | 8.4B |
| Long-Term Investments | 1.8B |
| PP&E | 6.2B |
| Intangibles | 219.8m |
| Other Non-Current Assets | 104.4m |
Balance Sheet
Formosa Laboratories Inc
Formosa Laboratories Inc
Currency: TWD
Millions
Annual
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
405
|
419
|
347
|
619
|
872
|
454
|
581
|
730
|
1 279
|
1 526
|
|
| Cash |
405
|
419
|
347
|
619
|
872
|
454
|
581
|
730
|
1 168
|
1 301
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
111
|
225
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
6
|
26
|
231
|
364
|
351
|
984
|
|
| Total Receivables |
713
|
942
|
887
|
849
|
896
|
907
|
785
|
803
|
827
|
1 024
|
|
| Accounts Receivables |
683
|
909
|
870
|
832
|
874
|
885
|
760
|
771
|
812
|
960
|
|
| Other Receivables |
30
|
33
|
18
|
17
|
21
|
21
|
25
|
32
|
15
|
64
|
|
| Inventory |
957
|
1 113
|
932
|
913
|
1 290
|
1 247
|
1 451
|
1 639
|
1 602
|
1 597
|
|
| Other Current Assets |
60
|
90
|
76
|
99
|
165
|
115
|
100
|
84
|
92
|
111
|
|
| Total Current Assets |
2 136
|
2 563
|
2 243
|
2 480
|
3 228
|
2 749
|
3 148
|
3 619
|
4 151
|
5 244
|
|
| PP&E Net |
2 930
|
3 027
|
3 280
|
3 608
|
4 224
|
5 641
|
5 917
|
5 986
|
5 978
|
6 095
|
|
| PP&E Gross |
2 930
|
3 027
|
3 280
|
3 608
|
4 224
|
5 641
|
5 917
|
5 986
|
5 978
|
6 095
|
|
| Accumulated Depreciation |
645
|
803
|
1 051
|
1 338
|
1 611
|
1 923
|
2 308
|
2 631
|
3 038
|
3 459
|
|
| Intangible Assets |
17
|
22
|
24
|
343
|
269
|
246
|
238
|
217
|
192
|
174
|
|
| Goodwill |
0
|
0
|
0
|
0
|
82
|
31
|
31
|
31
|
31
|
31
|
|
| Long-Term Investments |
554
|
787
|
1 133
|
733
|
830
|
779
|
846
|
2 083
|
2 254
|
1 950
|
|
| Other Long-Term Assets |
54
|
58
|
54
|
79
|
91
|
126
|
106
|
80
|
144
|
144
|
|
| Other Assets |
0
|
0
|
0
|
0
|
82
|
31
|
31
|
31
|
31
|
31
|
|
| Total Assets |
5 690
N/A
|
6 456
+13%
|
6 734
+4%
|
7 242
+8%
|
8 725
+20%
|
9 572
+10%
|
10 286
+7%
|
12 017
+17%
|
12 751
+6%
|
13 636
+7%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
133
|
182
|
197
|
163
|
230
|
268
|
208
|
204
|
187
|
203
|
|
| Accrued Liabilities |
213
|
253
|
295
|
267
|
265
|
221
|
267
|
394
|
451
|
486
|
|
| Short-Term Debt |
667
|
847
|
399
|
579
|
350
|
1 012
|
1 268
|
1 177
|
1 500
|
1 534
|
|
| Current Portion of Long-Term Debt |
292
|
462
|
785
|
984
|
243
|
631
|
342
|
313
|
641
|
472
|
|
| Other Current Liabilities |
165
|
149
|
255
|
291
|
265
|
342
|
955
|
298
|
362
|
546
|
|
| Total Current Liabilities |
1 469
|
1 893
|
1 931
|
2 284
|
1 354
|
2 473
|
3 040
|
2 386
|
3 142
|
3 241
|
|
| Long-Term Debt |
1 155
|
1 076
|
672
|
583
|
2 613
|
2 506
|
1 869
|
1 930
|
1 659
|
2 057
|
|
| Deferred Income Tax |
20
|
18
|
17
|
92
|
90
|
24
|
23
|
24
|
25
|
24
|
|
| Minority Interest |
0
|
0
|
0
|
81
|
150
|
96
|
81
|
207
|
276
|
639
|
|
| Other Liabilities |
12
|
8
|
11
|
183
|
111
|
111
|
67
|
75
|
129
|
103
|
|
| Total Liabilities |
2 655
N/A
|
2 994
+13%
|
2 631
-12%
|
3 222
+22%
|
4 318
+34%
|
5 210
+21%
|
5 081
-2%
|
4 622
-9%
|
5 230
+13%
|
6 065
+16%
|
|
| Equity | |||||||||||
| Common Stock |
844
|
875
|
887
|
930
|
990
|
990
|
1 083
|
1 203
|
1 203
|
1 203
|
|
| Retained Earnings |
391
|
508
|
814
|
783
|
1 031
|
992
|
1 390
|
2 640
|
2 809
|
2 810
|
|
| Additional Paid In Capital |
1 478
|
1 589
|
1 678
|
2 050
|
2 384
|
2 384
|
2 733
|
3 503
|
3 514
|
3 552
|
|
| Unrealized Security Profit/Loss |
322
|
490
|
725
|
265
|
0
|
2
|
2
|
58
|
4
|
20
|
|
| Other Equity |
0
|
0
|
0
|
8
|
2
|
2
|
2
|
9
|
10
|
14
|
|
| Total Equity |
3 035
N/A
|
3 462
+14%
|
4 104
+19%
|
4 019
-2%
|
4 407
+10%
|
4 362
-1%
|
5 205
+19%
|
7 395
+42%
|
7 521
+2%
|
7 571
+1%
|
|
| Total Liabilities & Equity |
5 690
N/A
|
6 456
+13%
|
6 734
+4%
|
7 242
+8%
|
8 725
+20%
|
9 572
+10%
|
10 286
+7%
|
12 017
+17%
|
12 751
+6%
|
13 636
+7%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
86
|
89
|
90
|
94
|
100
|
100
|
108
|
120
|
120
|
120
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
